BioNexus Gene Lab (BGLC) Asset Writedowns and Impairment (2022 - 2026)
BioNexus Gene Lab (BGLC) reported Asset Writedowns and Impairment of $202497.0 for Q1 2026, up 404.68% on a YoY basis from $40124.0 in Q1 2025, and up 193.77% sequentially from -$215942.0 in Q4 2025.
BioNexus Gene Lab (BGLC) Asset Writedowns and Impairment (2022 - 2026) Analysis & Trends
BioNexus Gene Lab (BGLC) has 5 years of Asset Writedowns and Impairment data on file, last reported at $202497.0 in Q1 2026.
- For the quarter ending Q1 2026, Asset Writedowns and Impairment rose 404.68% year-over-year to $202497.0; the trailing twelve-month figure through Mar 2026 stood at $162373.0 (down 79.83% YoY), and the FY2024 full-year result was $883533.0, up 14164.34% from the prior year.
- Asset Writedowns and Impairment advanced to $202497.0 in Q1 2026, from -$215942.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $760690.0 in Q4 2024 to a low of -$215942.0 in Q4 2025.
- A 5-year average of $107982.4 and a median of $4165.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
- Across the five-year window, Asset Writedowns and Impairment jumped 37576.57% in 2024 and slumped 128.39% in 2025, its largest moves.
- Tracing BGLC's Asset Writedowns and Impairment over 5 years: stood at $4165.0 in 2022, then slumped by 51.52% to $2019.0 in 2023, then jumped by 37576.57% to $760690.0 in 2024, then tumbled by 128.39% to -$215942.0 in 2025, then soared by 193.77% to $202497.0 in 2026.
- Business Quant data shows BGLC's Asset Writedowns and Impairment at $202497.0 in Q1 2026, -$215942.0 in Q4 2025, and $175818.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Linde | 237.95 Bn | 233.99 Bn | 4.26 Bn |
| 2 | Sherwin Williams | 78.17 Bn | 77.95 Bn | 2.78 Bn |
| 3 | Ecolab | 76.02 Bn | 75.37 Bn | 1.85 Bn |
| 4 | Air Products & Chemicals | 66.38 Bn | 65.43 Bn | 987.40 Mn |
| 5 | Ppg Industries | 26.02 Bn | 24.40 Bn | 1.66 Bn |
| 6 | LyondellBasell Industries | 22.51 Bn | 19.87 Bn | 701.00 Mn |
| 7 | Chemical & Mining Co Of Chile | 19.70 Bn | 15.83 Bn | 778.60 Mn |
| 8 | International Flavors & Fragrances | 19.51 Bn | 18.95 Bn | 1.02 Bn |
| 9 | DuPont de Nemours | 18.80 Bn | 18.71 Bn | 602.00 Mn |
| 10 | BioNexus Gene Lab | 2.82 Mn | -1.14 Mn | -790.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 202,497.00 |
| Mar 31, 2026 | 202,497.00 |
| Dec 31, 2025 | -215,942.00 |
| Dec 31, 2025 | -215,942.00 |
| Sep 30, 2025 | 175,818.00 |
| Sep 30, 2025 | 175,818.00 |
| Mar 31, 2025 | 40,124.00 |
| Mar 31, 2025 | 40,124.00 |
| Dec 31, 2024 | 760,690.00 |
| Dec 31, 2024 | 760,690.00 |
| Sep 30, 2024 | 2,374.00 |
| Sep 30, 2024 | 2,374.00 |
| Dec 31, 2023 | 2,019.00 |
| Dec 31, 2023 | 2,019.00 |
| Sep 30, 2023 | 97.00 |
| Sep 30, 2023 | 97.00 |
| Dec 31, 2022 | 4,165.00 |
| Dec 31, 2022 | 4,165.00 |